| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1500032 | 重组人源抗人肿瘤坏死因子(TNF-α)单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-05-13 | 华北制药集团新药研究开发有限责任公司 | North China Pharmaceutical Group New Drug R&D Co Ltd | Certificate Issued | 2017-02-13 | view |